Genomatix and Personalized Medicine.

Personalized Medicine for Scientists

 

Status quo

Still half empty or already half full?

Some speak of a new era, some of a revolution of medicine. Big words for a research area that has been around for quite a while. Challenges still need to be overcome, but several milestones have already been reached. Today, the time is finally right for personalized medicine to leave the research labs and make inroads into society.


As a matter of fact, next-generation sequencing technology is rapidly changing the scientific landscape. Truly a technology that opens doors, it promises to take biomedical research to the next level. Data of exponentially greater quality and quantity can now be obtained and mined for a deeper understanding of biological and medical questions. The technology's increasing efficiency will soon allow epigenomes, genomes and transcriptomes to be sequenced on an individual basis, thus improving knowledge of a given patient's diseases and predisposition.


Yet one question remains: How, and how quickly, will the progress in sequencing technology and data analysis influence developments in personalized medicine? Many challenges still lie ahead, but the increasing demand for improved diagnostics and treatment ensures that personalized medicine will become a reality.


For scientists and patients, treatments based on highly differentiated genetic diagnostics are becoming more feasible. And, in spite of the "ifs" and "buts," it is clear that scientists have long sought to achieve individualized therapies. Now is the right time to make this vision a reality.

New Perspectives

Paving the way

Personalized medicine is a huge scientific challenge, yet it opens up a vista for inspired approaches and innovative applications. Tumor diseases are of high public relevance, given their incidence and the fact that even state-of-the-art treatments can have limited success. Diabetes, cardiovascular diseases and autoimmune disorders are equally important areas in which ground-breaking research could substantially improve diagnosis and treatment.

 

Our contribution

Taking on the challenge

Genomatix solutions and technologies can effectively support researchers in answering important questions: Where are mutations in a gene located, and what defects can be identified? What specific genes are affected? What mechanisms are the identified genes involved in? Are these mechanisms relevant to tumor development – in a cancer cell, for example?


A significant amount of research has already gone into each of these questions. And new technologies such as next-generation sequencing produce even more data. The challenge is to go beyond conventional means of viewing data as isolated bits and pieces, and to move toward identifying relevant connections and dependencies. Always attuned to your needs, Genomatix develops multi-evidence approaches to deliver data quality combined with more relevant results that demonstrate deeper scientific understanding.


As scientists ourselves,  we are intimately familiar with research work, and compelled to deliver exact, reliable results. We are committed to offering the best possible platform for efficient and successful research – to help you reach your milestones in personalized medicine faster and welcome a new era of treatment.